This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Pharmaceutical University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Siling Wang
Introduction
Siling Wang is a notable inventor based in Liaoning, China. He has made significant contributions to the field of medicinal chemistry, particularly through his research on peptides derived from scorpions. His work focuses on developing innovative solutions for pain relief and cancer treatment.
Latest Patents
Siling Wang holds a patent for a "Method of using a peptide having analgesic and antitumor activity from scorpion." This invention relates to a peptide that exhibits both analgesic and antitumor properties. The peptide is obtained through extraction, isolation, and purification from scorpions or their venom. Additionally, it can be synthesized chemically or through bioengineering methods. The applications of this peptide are primarily in the development of analgesic and antitumor drugs.
Career Highlights
Siling Wang is affiliated with Shenyang Pharmaceutical University, where he contributes to research and education in pharmaceutical sciences. His work has garnered attention for its potential impact on pain management and cancer therapies. With 1 patent to his name, he continues to explore the therapeutic possibilities of scorpion-derived peptides.
Collaborations
Siling Wang collaborates with esteemed colleagues, including Yanfeng Liu and Runlin Ma. Their combined expertise enhances the research efforts at Shenyang Pharmaceutical University, fostering innovation in the field of medicinal chemistry.
Conclusion
Siling Wang's innovative research on scorpion-derived peptides highlights the potential for new therapeutic agents in pain relief and cancer treatment. His contributions to the field are paving the way for future advancements in medicinal applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile